Breakthroughs in Mental Health and Market Implications

This chapter explores the recent FDA approval of an innovative schizophrenia medication, emphasizing its advantages over traditional antipsychotics, particularly in terms of side effects. The discussion also considers the wider implications of such healthcare advancements for patients and the pharmaceutical industry.